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Background: Osteoradionecrosis (ORN) is one of the most serious complications of head and neck radiotherapy 
and is considered a public health problem worldwide. This study aims to determine the prevalence and associated 
factors of ORN in patients undergoing radiotherapy for head and neck malignancy. 
Material and Methods: A cross-sectional retrospective study was conducted, in which all medical records of pa-
tients undergoing head and neck radiation in the period between 2006 to 2015 (10 years) were examined. Clinical 
and demographic data were extracted. Multivariate Poisson regression analysis with robust variance was em-
ployed to access the relationship between ORN and independent variables (p < 0.05; 95% CI). 
Results: The sample comprised 413 medical records of patients undergoing radiotherapy. The prevalence of ORN 
was 9.7 %. Most participants were males (78.2%). The mean age of subjects was 55 years (± 14 years). The man-
dible was the main site of occurrence of ORN (85.0%). The following variables were associated with ORN : pres-
ence of oral mucositis (PR = 3.03; 95% CI: 1.30-7.03), history of smoking (PR = 0.23; 95% CI: 0.07-0.74), number 
of teeth removed before radiotherapy (PR = 1.06; 95% CI: 1.01-1.11) and visit to the dentist before radiation (PR = 
0.08; 95% CI: 1.02-1.11). 
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Introduction
Osteoradionecrosis (ORN) is one of the most serious 
complications of head and neck radiotherapy and is 
considered a public health problem worldwide (1). It is 
characterized by defects in healing and the loss of bone 
viability, induced by the tissue effects of radiation (2). 
The mandible is the most affected bone, as it is frequent-
ly present in the radiation field, which exerts an impor-
tant influence on the development of ORN (3). Initially, 
ORN may appear as asymptomatic bone changes, with 
decreased bone density in the irradiated region, delayed 
healing and destruction of the cortical bone. However, 
it is most commonly characterized by the exposure of 
the affected bone, in addition to oral ulcers, drainage 
of purulent secretion and oral fistulas. Pain, foul odor, 
discomfort in masticatory, swallowing, and speech dif-
ficulties are the most common complications. In some 
cases, pathological fractures have also be observed (4). 
The prevalence and incidence of ORN have been report-
ed in the literature with a variation of 5-10% (5,6). In ad-
dition, several risk factors have been suggested for the 
onset of ORN, with emphasis on the post-radiotherapy 
exodontia. Important studies indicate the importance 
of integrated treatment plan for these patients (7). The 
objective of this study was to analyze the prevalence of 
ORN in the jaws, in a 10-year retrospective study, as 
well as the associated factors.
Material and Methods
A cross-sectional, retrospective, and analytical study 
was carried out at the Dentistry School of the Federal 
University of Minas Gerais, Belo Horizonte, Brazil, a 
reference center in the dental care of patients with head 
and neck cancer. The study sample comprised the medi-
cal records of all patients with head and neck cancer 
treated between 2006 and 2015, who underwent radio-
therapy.  
-Data collection
The records were carefully examined by a previously 
trained researcher, who searched the following vari-
ables: age, gender, skin color, type of malignancy, lo-
cation of lesion, alcohol and tobacco consumption his-
tory, radiotherapy (total dose, number of sessions), bone 
affected and number of dental extractions performed 
prior to radiotherapy.
-Data analysis
Data were analyzed using descriptive and inferential 
statistics, applying the Statistical Package for Social 
Sciences (SPSS for Windows, version 23.0, IBM Inc., 
Amonk, NY, USA). After having performed a descrip-
tive analysis, a Poisson multiple regression analysis with 
robust variance was performed, in which an association 
between the dependent variable (osteoradionecrosis) 
and the independent variables was adopted, respecting 
a 95% confidence level (p<0.05). The variables with 
p<0.20 in the bivariate analysis were included in the 
multiple analysis; those with p<0.05 were maintained 
in the final model.
-Ethical aspects
The present study was carried out following the ethi-
cal precepts of Resolution 466/12 of the National Health 
Council, as well as those of the Declaration of Helsinki. 
Information was only accepted from medical records 
that had been correctly filled out, that contained the pa-
tients’ authorizations, and that had a free and informed 
consent form that had been properly signed. This study 
was approved by the local Research Ethics Committee 
(protocol: CAAE-47197715.0.0000.5149).
Results
The study evaluated 413 charts of patients submitted to 
head and neck radiotherapy between January 2006 and 
December 2015. Table 1 presents the characteristics of 
the study. The prevalence of ORN was 9.7% (n = 40 
cases). The majority of the patients were male (78.2%) 
and had a mean age of 55 years (± 14). Squamous cell 
carcinoma (76.3%) was the most common type of can-
cer, predominantly affecting the oral cavity (42.2%). On 
average, patients received a radiation dose of 60.43 Gy 
(± 8.23) and removed 9.9 teeth (± 6.5). ORN proved to 
be more frequent in the mandible (85%).
Table 2, 2 continue shows the ORN frequency accord-
ing to the independent variables. In the final model, 
ORN presence was associated with the presence of oral 
mucositis  (OM) (PR = 3.03, 95% CI: 1.30-7.03), history 
of smoking (PR = 0.23, 95% CI: 0.07-0.74), number of 
teeth removed (PR = 1.06; 95% CI: 1.01-1.11) and visits 
to the dentist before radiotherapy (PR = 0.08; 95% CI: 
1.02-1.11).  
Discussion
Osteoradionecrosis of the jaws is one of the major com-
plications of radiotherapy in the head and neck region. 
Despite of protective actions, it can not always be avoid-
Conclusions: The prevalence of ORN was low and was associated with the presence of oral mucositis and the number 
of removed teeth before radiation. Visiting the dentist before radiotherapy and stopping smoking were protective 
factors for ORN.
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≤ 55 years 207 50.1
> 55 years 206 49.9
Type of cancer
Others 98 23.7
Squamous cell carcinoma 315 76.3
Site of tumor
Other 238 57.8
Oral cavity 174 42.2





















Radiation dose 60.43 8.23
Number of removed teeth  
before radiation
9.97 6.55
Table 1. Characteristics of the 413 patients submitted to head and 
neck radiotherapy in a ten years period.
ed, causing psychological and physical impact on can-
cer patients (6).
A total of 413 medical records of patients with malig-
nant head and neck neoplasms were evaluated over a 10-
year period, with 40 cases of osteoradionecrosis (9.7%) 
diagnosed. There is a great variation in the prevalence 
and incidence of ORN in several studies, but the result 
observed in the present study is similar to more recent 
researches, which predominately identify the frequency 
of ORN between 4-10% (5,8). In addition, the risk of 
developing ORN has declined in recent years due to 
advances in radiotherapy and the introduction of pre-
radiotherapy dental care (9). However, it is difficult to 
compare the present data with other studies due to a 
lack of standardization of diagnoses and classifications 
of ORN, different tumor locations, varied radiation/
dosing techniques and sample size. 
Although not statistically different, individuals diag-
nosed with ORN were mostly men, with a mean age of 
55 years. Other studies also found similar demographic 
data, where 72.7% - 76.0% were men, categorized in 
the fifth decade of life (6,10,11). This higher occurrence 
in the male sex can be justified by the harmful habits 
practiced by men, such as higher consumption of alco-
hol and tobacco and less care with oral hygiene (10,12). 
The main site of primary tumors in the head and neck 
region was the oral cavity (45%), with squamous cell 
carcinoma being the most frequent (77.5%). Several au-
thors also found the main localization of the tumor in 
the oral cavity, ranging between 53.6% (10), 60.6%(6) 
and 74%(11). Tumor location is an important factor in 
ORN risk prediction, because the radiotherapy of tu-
mors in the oral cavity or oropharynx probably includes 
the mandible in the radiation field (9).    
The mandible was most affected by ORN than maxilla 
(85%). According to the previous studies, the mandible 
is affected in approximately 90% of the cases (6,13). It 
has a greater risk of developing osteoradionecrosis than 
the maxilla because of the difference in anatomy and 
bone density, as well as the lower blood supply (6,9,14).
The pathogenesis and etiology of ORN have been ex-
plained by several hypotheses. The most accepted is the 
theory of “hypoxia, hypocellularization, and hypovas-
cularization” (13). In addition, several risk factors have 
been reported to the development of ORN: radiation 
dose, pre-radiotherapy surgery, associated chemother-
apy, oral health status, dental surgery, tumor location, 
comorbidities and alcohol and tobacco abuse (5,9-11). 
In the present study, the following variables presented a 
statistically significant association with ORN: the pres-
ence of oral mucositis, history of smoking, dental ex-
traction before to radiotherapy and having gone to the 
dentist before radiotherapy.
A previous study found a prevalence of oral mucositis 
in irradiated patients with head and neck neoplasms is 
















Female 8(8.9) 82(91.1) 1.00 - -
Male 32(9.9) 291(90.1) 0.774 1.115(0.532-2.333) - -
Age
≤ 55 years 22(10.5) 185(89.4) 0.334 1.509(0.655-3.480) - -
> 55 years 18(8.7) 188(91.3) 1.00 - -
Type of cancer
Others 9(9.2) 89(90.8) 1.00 - -
Squamous cell carcinoma 31(9.8) 284(90.2) 0.913 1.040(0.513-2.111) - -
Site of tumor
Other 22(9.2) 216(90.8) 1.00 - -
Oral cavity 18(10.3) 156(89.7) 0.633 1.157(0.637-2.101) - -
History of alcohol use
No 7(10.9) 57(89.1) 1.00 - -
Yes 33(9.5) 316(90.5) 0.674 0.846 (0.392-1.832) - -
Smoking
No 3(6.8) 41(93.2) 1.00 1.00
Yes 24(15.2) 134(84.8) 0.107 3.158(0.779-12.804) 0.460 0.645(0.202-2.062)
Stopped 13(6.2) 198(93.8) 0.713 1.313(0.308-5.595) 0.014 0.230(0.071-0.742)
Oral Mucositis
No 10(4.2) 230(95.8) 1.00 1.00
Yes 30(17.3) 143(82.7) 0.003 3.816(1.560-9.212) 0.010 3.034(1.309-7.030)
Adjuvant Chemotherapy
No 12(6.0) 188(94.0) 1.00 - -
Yes 28(13.1) 185(86.9) 0.063 2.308(0.955-5.575) - -
Oral
Candidiasis
No 29(8.6) 310(91.4) 1.00 - -
Yes 11(14.9) 63(85.1) 0.118 1.948(0.845-4.492) - -
Visited the dentist before 
radiation
No 16(7.3) 204(92.7) 1.00 1.00
Yes 24(12.4) 169(87.6) <0.001 0.182(0.074-0.446) <0.001 0.089(0.031-0.257)
Table 2. Bivariate and multivariate Poisson regression analysis regarding the association of ORN and independent variables among patients 
undergoing radiotherapy.
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0.030 1.044(1.004-1.085) - -






0.002 1.072(1.027-1.119) 0.004 1.065(1.021-1.112)
Table 2 continue. Bivariate and multivariate Poisson regression analysis regarding the association of ORN and independent variables among 
patients undergoing radiotherapy.
* Unadjusted Poisson regression analysis  
** Variables incorporated in multivariate model (p < 0.20): mucositis, radiation dose, smoking, chemotherapy, number of removed teeth, visited 
the dentist before radiation. 
approximately 80% (15), much higher than the present 
study (41.9%). In this study, patients with oral mucosi-
tis had a prevalence of ORN approximately three times 
greater. Few studies shows the relation between the two 
complications, since oral mucositis is an acute condi-
tion, whereas ORN is a chronic condition. However, 
this relationship can be explained since both conditions 
have a common risk factor: elevated dose of radiation 
and the association with chemotherapy and radiation 
field (16). 
The oral health status of patients with head and neck 
neoplasms is much more unfavorable than the general 
population, due to alcohol and tobacco abuse, coupled 
with poor oral hygiene (5,17). Patients with poor oral 
hygiene and dental extractions after radiotherapy are 
associated with an increased risk for the development 
of ORN (11). 
An average of 9.97 teeth were removed before radia-
tion. The present study found that exodontia performed 
before radiotherapy is a factor associated with ORN. 
This result must be interpreted with caution, as despite 
statistically significant, the low difference between 
groups suggests that this variable may be not clinically 
important. Although radiotherapy should begin at least 
15 days after oral surgery, this interval is not always 
obeyed due to the severity of the cancer. However, visit-
ing the dentist before radiation therapy was a protective 
factor. 
The excessive consumption of alcohol and tobacco is 
another risk factor for ORN. A previous study observed 
a 32% increase in the incidence of ORN in patients who 
smoked during radiotherapy (11,18,19). In the present 
study, 82.5% of the patients with ORN had a history 
of alcohol use and 92.5% had a history of tobacco use. 
It was also observed that stopping smoking was a pro-
tective factor for ORN. Patients who stopped smoking 
presented significantly less ORN, a fact that can be ex-
plained by tobacco interference in healing processes, as 
well as aggression to the oral mucosa (8). 
Despite being limited by the cross-sectional design, the 
results of this investigation should not be disregarded. 
Our findings reinforce that the use of oral adequacy pro-
tocols prior to radiochemotherapy treatment, is essen-
tial to prevent complications such as ORN. Removing 
compromised teeth before radiotherapy is as important 
as respecting a minimal period of alveolar healing.
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